Muscle loss from rapid weight loss One of the most significant contributors to body aches on GLP-1 medications is muscle mass loss
A review on endocrine disruptors and their possible impacts on human health
PYY 336 , a truncated peptide agonist derived from dipeptidyl peptidase IV (DPPIV)-mediated proteolysis of full-length PYY 136 , is of particular interest as it binds preferentially to the anorectic neuropeptide Y2-R 10,11,12,17,25
DPP-4 Inhibition Idea: By early 1990s, based on the above, two possible solutions emerged
This evolving landscape is further complicated by the body positivity movement, which challenges traditional pathologizing frameworks and advocates for a broader appreciation of body diversity and health beyond BMI